Insider Holders & Insider Ownership - AGENUS INC (AGEN)

List of insiders holdings for AGENUS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
INCYTE CORP
10% Owner		2022-02-11 16:00:2212,070,195
0		12,070,195Form 13G
QVT Associates GP LLC
QVT Fund V LP
10% Owner		2015-01-13 17:35:310
6,915,630		6,915,630Form 4
KELLEY BRAD M
10% Owner		2004-05-25 15:39:055,546,740
0		5,546,740Form 4/A
Invus Public Equities LP
Invus Public Equities Advisors LLC
Ulys LLC
DEBBANE RAYMOND
10% Owner		2012-02-13 12:24:124,546,079
0		4,546,079Form 13G
CHADAREVIAN GAMIL DE
Director		2006-03-02 09:33:18221,802
1,479,488		1,701,290Form 4
HERNDON RUSSELL
Pres, Commercial Operations		2004-12-13 15:17:51375,000
0		375,000Form 4
Buell Jennifer
Chairman Executive Council		2024-11-18 16:05:05300,000
0		300,000Form 4
JORDAN WADIH
Director		2022-10-05 13:07:24239,945
0		239,945Form 4
Cuillerot Jean-Marie
Chief Medical Officer		2017-04-04 18:27:17232,500
0		232,500Form 4
ARMEN GARO H
See Remarks		2024-12-16 16:05:09118,440
60,248		178,688Form 4
Krauss Adam
Chief Legal Officer		2021-07-02 17:57:25175,000
0		175,000Form 4
Valentine Karen
Chief Legal Officer and GC		2018-06-22 11:16:37173,150
0		173,150Form 4
Baysal Ozer
Chief Commercial Officer		2018-06-22 11:24:15165,000
0		165,000Form 4
CLARK JEFF D
Chief Financial Officer		2004-02-20 11:15:45150,000
0		150,000Form 4
Kearns Evan
VP and General Counsel		2020-12-21 13:42:15150,000
0		150,000Form 4
GORDON NEAL
SrVP, Manufacturing Operations		2004-02-20 11:32:07139,189
0		139,189Form 4
Stein Robert Benjamin
President R&D		2017-04-04 18:42:47100,000
0		100,000Form 4
Ballantyne Charles Evan
CFO		2016-06-16 21:55:5389,000
0		89,000Form 4
KESSEL MARK
Director		2006-10-05 14:54:0585,630
0		85,630Form 4
Sharp Shalini
Director		2018-06-22 12:16:0666,033
0		66,033Form 4
Wentworth Kerry
VP, Clinical, Reg & Qual		2014-02-28 16:16:4657,410
0		57,410Form 4
Thornton Peter
Director		2008-06-06 10:58:5055,000
0		55,000Form 4
O'Day Steven J
Chief Medical Officer		2024-11-18 16:05:0350,000
0		50,000Form 4
Malik Shahzad
Director		2016-06-17 14:07:1135,000
0		35,000Form 4
Duncan Alex
Chief Technology Officer		2019-07-25 19:12:1130,000
0		30,000Form 4
WIINBERG ULF
Director		2024-10-03 08:40:0419,501
0		19,501Form 4
Cortis Christian
Chief Strategy Officer		2019-07-25 19:32:5018,333
0		18,333Form 4
Wright Timothy
Director		2024-10-03 08:39:5911,671
0		11,671Form 4
KLASKIN CHRISTINE M
PFO & PAO		2024-11-18 16:05:1410,000
0		10,000Form 4
Hirsch Susan B
Director		2024-10-03 08:38:179,790
0		9,790Form 4
CLARK PAUL N
Director		2021-04-05 17:45:065,093
0		5,093Form 4
Jeynes-Ellis Allison M
Director		2024-04-22 16:05:115,000
0		5,000Form 4
HARRISON THOMAS L
Director		2024-08-08 16:45:041,250
0		1,250Form 3
Corvese Brian
Director		2024-06-18 16:05:03750
0		750Form 4
DECHAENE TOM
Director		2016-01-06 16:02:56636.88
0		636.88Form 4
Wood Alastair JJ
Director		2006-09-19 12:52:030
0		0Form 4
GUPTA RENU
Sr. VP Development		2006-07-24 08:40:300
0		0Form 4
ATLEE FRANK V III
Director		2007-06-11 11:25:010
0		0Form 4
Leicher Bruce
VP, General Counsel		2006-12-18 08:56:200
0		0Form 4
AFEYAN NOUBAR
Director		2007-06-11 11:23:270
0		0Form 4
Levitsky Hyam
Director		2011-09-16 12:48:300
0		0Form 4
SRIVASTAVA PRAMOD
Director		2007-06-11 11:26:520
0		0Form 4
Chicz Roman
Sr. VP, Research & Development		2007-06-11 11:30:030
0		0Form 4
MARGARET EISEN
Director		2009-06-15 10:59:000
0		0Form 4
ROTHWELL TIMOTHY G
Director		2011-12-12 12:43:200
0		0Form 4
HATSOPOULOS JOHN
Director		2011-12-12 12:41:360
0		0Form 4